19/3 2026
The global wound dressing market reached $12.8 billion in 2025 and is growing at 7.6% annually. For procurement managers and distributors, navigating product types, regulatory standards, and supplier qualification has never been more complex. This guide covers everything you need to make informed sourcing decisions — from foam vs hydrocolloid selection to CE compliance and China OEM audit frameworks.
Foam and hydrocolloid dressings are frequently substituted for each other in purchase orders when one is unavailable. They are not clinically equivalent — foam manages high exudate; hydrocolloid is designed for moist wound healing environments with low to moderate output. Substituting incorrectly can compromise patient outcomes and expose procurement teams to clinical liability.
Before specifying any wound dressing in a purchase order, confirm the exudate level the product needs to manage. Low exudate → hydrocolloid or transparent film. Moderate → foam or island dressing. High to very high → absorbent pad or high-capacity foam. Getting this wrong drives unnecessary dressing change frequency and inflates total cost of care.
| Product Type | EU MDR Class | Notified Body? | Key Requirement |
|---|---|---|---|
| Standard gauze / non-adherent pad | Class I | No | Self-declaration, Technical File |
| Foam dressing (non-medicated) | Class IIa | Yes | ISO 10993, EN 13726 test data |
| Hydrocolloid dressing | Class IIa | Yes | Clinical data, gel characterization |
| Transparent PU film | Class I / IIa | Depends | MVTR data, adhesive biocompatibility |
| Island dressing (adhesive border) | Class IIa | Yes | ISO 10993 for adhesive, EN 13726 |
| Antimicrobial / silver dressing | Class IIb | Yes | Clinical evidence, antimicrobial efficacy data |
| Vaseline / medicated gauze | Class I / IIa | Depends | Petroleum characterization, biocompatibility |
The EU Medical Devices Regulation (MDR 2017/745) fully replaced the Medical Devices Directive (MDD 93/42/EEC) in May 2021. Some Chinese suppliers continue to present MDD certificates, which are no longer valid for new EU market access. Always verify that CE certificates reference EU MDR 2017/745 with a valid Notified Body number and expiry date.
For Chinese manufacturers and their distributors, the GCC market presents specific compliance requirements that go beyond standard CE or FDA certification. Each GCC country operates its own medical device registration system, and registration in one country does not automatically confer access to others.
Government hospital tenders across GCC states increasingly include sustainability scoring (ESG criteria), CE/FDA documentation completeness, and Arabic labeling compliance as mandatory pre-qualification criteria. Suppliers unable to produce complete technical documentation — including ISO 10993 biocompatibility test reports, EN 13726 absorption data, and valid CE certificates referencing MDR 2017/745 — are routinely disqualified at the document review stage before pricing is even evaluated.
| Parameter | What to Specify | Why It Matters |
|---|---|---|
| Size | Length × Width in cm (e.g. 10×10, 15×15, 20×20) | Standardize for formulary management |
| Foam type | Polyurethane foam, silicone-coated face or standard | Silicone reduces trauma at removal |
| Format | Adhesive border or non-adhesive | Determines secondary dressing requirement |
| Absorption capacity | g/10cm² per EN 13726 test method | Quantifiable exudate management performance |
| MVTR | g/m²/24h per EN 13726 Part 2 | Determines moisture balance capability |
| Sterility | EO or Gamma sterilized; sterility assurance level 10⁻⁶ | Required for wound contact use |
| Parameter | What to Specify | Why It Matters |
|---|---|---|
| Size | Standard sizes: 10×10, 15×15, 20×20 cm | Match to wound coverage requirements |
| Profile | Standard or thin (≤3mm thickness) | Thin profiles allow use under compression |
| Border | Bordered (adhesive edge) or borderless | Affects application technique and security |
| Gel composition | CMC (carboxymethylcellulose) base — specify % | Determines gel consistency and absorption rate |
| Wear time | Up to X days continuous wear (validated claim) | Clinical protocol and cost-per-day calculation |
| Backing | Polyurethane film backing required | Water resistance and conformability |
The Chinese wound dressing manufacturing landscape is highly fragmented. Large facilities with ISO 13485 certification, dedicated cleanrooms, and in-house testing laboratories exist alongside smaller contract manufacturers who outsource critical processes. The distinction matters enormously for long-term supply reliability and quality consistency.
| Tier | Characteristics | Suitability | Risk Profile |
|---|---|---|---|
| Tier 1 — Integrated Manufacturer | Own raw material processing, full production in-house, ISO 13485, CAPA system, in-house lab | Hospital tenders, large distributor programs, CE/FDA markets | Low |
| Tier 2 — Specialized Manufacturer | Focused on 2–3 product categories, ISO 13485, some outsourcing, CE certification | Mid-volume B2B procurement, OEM programs | Medium |
| Tier 3 — Trading / Assembly | Sources components from multiple factories, minimal quality system, CE may not reflect actual production site | Low-cost commodity procurement only — with verified inspection | High |
Request and verify: ISO 13485 certificate with scope statement, CE certificates with Notified Body reference number (verify at NANDO database), FDA establishment registration number (verify at FDA database), ISO 10993 biocompatibility reports for wound contact materials, EN 13726 test reports from accredited laboratory, and the most recent internal audit report. A supplier who cannot produce these documents within 5 business days is unlikely to have a functional quality system.
Wound dressings requiring sterility must be manufactured in a controlled environment. Verify: cleanroom classification (ISO Class 7 or 8 minimum for pre-sterile assembly), airborne particle monitoring records, microbial environmental monitoring data, gowning procedures, and entry/exit control protocols. Ask specifically for the most recent cleanroom qualification report — not just the certificate.
For each major component (foam substrate, hydrocolloid matrix, adhesive, backing film, packaging), verify: approved supplier list with qualification records, incoming material inspection procedures, batch-level material traceability to finished product, and Certificate of Conformity for critical raw materials. Particular attention should be paid to adhesive materials — these carry the highest biocompatibility risk and are most frequently sourced without adequate qualification.
Request production batch records for a recent lot of the specific product you intend to order. Verify: in-process inspection checkpoints, finished product release criteria, retention sample program, and sterility testing program (if applicable). Ask to see the most recent out-of-specification (OOS) investigation — a manufacturer who has never had an OOS result either has excellent quality control or is not testing thoroughly.
Review the Corrective and Preventive Action (CAPA) log for the past 12 months. You are looking for evidence that the system is active (new CAPAs being raised and closed), that root cause analysis is genuinely conducted (not superficial), and that systemic issues are addressed, not just individual events. A dormant CAPA system is a significant quality system red flag regardless of certification status.
MOQ varies significantly by product type and format. For standard foam or hydrocolloid dressings, most established Chinese manufacturers work with MOQs of 5,000–20,000 units per SKU for standard sizes. Custom configurations (non-standard sizes, private label packaging, OEM branding) typically carry higher MOQs of 20,000–50,000 units. For initial qualification orders, many manufacturers will produce a smaller sample run — typically 500–1,000 units — at a higher unit cost.
Standard production lead time is 30–45 days for established products. OEM orders requiring custom packaging design, artwork approval, and new labeling artwork can extend to 60–90 days from purchase order confirmation. If regulatory documentation (CE certificate updates, product registration supplements) is required for the specific OEM configuration, add an additional 30–90 days depending on the registration authority involved.
Yes, provided the supplier holds both valid CE certification (MDR 2017/745) and has experience with GCC MOH registration requirements. However, buyers should verify that labeling, packaging, and documentation can be configured simultaneously for both markets. Arabic labeling requirements for GCC markets frequently require separate packaging runs from EU-spec products, which affects MOQ calculations and production scheduling.
CE certificates for Class IIa and above wound dressings are issued by EU Notified Bodies. Verify the certificate by locating the Notified Body number on the certificate and checking it against the European Commission's NANDO (New Approach Notified and Designated Organisations) database at ec.europa.eu/growth/tools-databases/nando. The database will confirm the Notified Body's accreditation scope. Note that many Chinese manufacturers present Class I self-declaration certificates — these are legitimate but do not involve Notified Body oversight.
Ethylene oxide (EO) sterilization is the standard method for most foam, hydrocolloid, and adhesive wound dressings — it does not affect adhesive properties or material integrity. Gamma irradiation is increasingly used and offers no residual chemical concerns, but can affect adhesive performance in some foam formulations and may discolour some hydrocolloid products. When specifying sterilization method for a purchase order, confirm with the supplier that their chosen method is validated for the specific product and that residual EO levels (if applicable) comply with ISO 10993-7 limits.
Kingphar manufactures foam dressings, hydrocolloid dressings, island dressings, transparent PU film, non-adherent pads, and vaseline gauze with CE certification and full documentation support for GCC, European, and North American markets.
Visit our blog center for the full archive of medical supply guides and industry news.
Back to Blog CenterKingphar Medical Group New’s 06/10 2026 No results See all results Table of Contents Incoming Quality Inspection (IQI) for Medical Consumables: Complete Guide Procurement Quality ·
Kingphar Medical Group New’s 06/10 2026 No results See all results Table of Contents Incoterms for Medical Supplies: FOB vs CIF vs DDP Explained (2026) Procurement
Kingphar Medical Group New’s 21/9 2026 No results See all results Table of Contents Inventory Management · Procurement Guide Medical ConsumablesShelf Life & ExpiryManagement Guide Shelf
Kingphar Medical Group New’s 31/8 2026 No results See all results Table of Contents Procurement Guide · Tender Writing How to Write Medical ConsumableTender SpecificationsThat Win
Kingphar Medical Group New’s 18/8 2026 No results See all results Table of Contents Procurement Guide · Import & Customs Medical ConsumablesImport Documentation:The Complete Checklist A
Kingphar Medical Group New’s 7/8 2026 No results See all results Table of Contents Procurement Guide · Import & Customs Medical Consumables HS Codes:Classification & ImportDuty
Cooperation, innovation and win-win
Don’t miss our future updates! Get Subscribed Today!
